Summer Sale
50% off Premium Yearly
Opinions Terry Shaunessy
Horizon's Medical MarijuanaHMMJ.TODON'T BUYJul 13, 2018
Stock price when the opinion was issued
As of Jun 19, 2026. Market Open.
You might be interested:
This asset class has been down for 5 years during a long period of investor apathy. But when an asset class has been down for longer than 3 years, you start to consider it. HMMJ has US exposure where there is growing public support for legalizing canopy. Maybe start with a small position. This is a volatile sector.
HMMJ vs. HMUS. A monstrous opportunity, but you're going to suffer volatility. Go slow, get in over time, and keep it to a smaller proportion of your portfolio. Market weighted. The US exposure is to companies operating legally, and there can't be any recreational use. With HMUS, you're tapping into a bigger market. For example, Charlotte's Web is planning to sell CBD infused products through Kroeger. This scale dwarfs the whole Canadian market. Valuations are high because of the growth potential. If you're a marijuana investing aficionado, you'd want to own both.
Good time to get in? His firm uses only ETFs. This is an example of where ETFs are not the way to go on themes. All the enthusiasm about marijuana is already baked in, so could sell off once it’s legal. Canopy Growth is the Phillip Morris of marijuana. Why pay the premium of the ETF, just buy Canopy Growth.